Efficacy and Patient Satisfaction of the Weekly DPP-4 Inhibitors Trelagliptin and Omarigliptin in 80 Japanese Patients with Type 2 Diabetes

OBJECTIVE: We investigated the efficacy, safety, and patient satisfaction of once-weekly DPP-4 inhibitors (DPP-4Is). METHODS: Either of two once-weekly DPP-4Is, trelagliptin or omarigliptin, was administered alone or in combination with other antidiabetic drugs in 80 outpatients with type 2 diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales: Tosaki, Takahiro, Kamiya, Hideki, Yamamoto, Yuka, Himeno, Tatsuhito, Kato, Yoshiro, Kondo, Masaki, Yamada, Yuichiro, Inagaki, Akemi, Tsubonaka, Kaori, Oshiro, Chie, Katayama, Takami, Hayasaki, Tomoyo, Nakaya, Yuki, Fujiyoshi, Haruna, Nakamura, Jiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658520/
https://www.ncbi.nlm.nih.gov/pubmed/28883229
http://dx.doi.org/10.2169/internalmedicine.8184-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658520/
https://www.ncbi.nlm.nih.gov/pubmed/28883229
http://dx.doi.org/10.2169/internalmedicine.8184-16

Ejemplares similares